![Jean-Paul St-Pierre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Paul St-Pierre
Keine laufenden Positionen mehr
Profil
Jean-Paul St-Pierre formerly worked at Synapse Technologies, Inc., as President & Chief Executive Officer, Ambrilia Biopharma, Inc., as Director from 2007 to 2010, Sandoz Canada, Inc., as Vice President-Scientific Development, Rhône-Poulenc, Inc., as VP-Worldwide Clinical Development Operations, and Hoechst Marion Roussel Canada, Inc., as Executive Vice President-Scientific Affairs.
Dr. St-Pierre received his doctorate degree from the University of Montréal.
Ehemalige bekannte Positionen von Jean-Paul St-Pierre
| Unternehmen | Position | Ende |
|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Direktor/Vorstandsmitglied | 31.03.2010 |
Hoechst Marion Roussel Canada, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Rhône-Poulenc, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops therapeutic enzymes for blood-brain barrier intravenous injections | Präsident | - |
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes injections & ophthalmic pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jean-Paul St-Pierre
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops therapeutic enzymes for blood-brain barrier intravenous injections | Health Technology |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Health Technology |
Sandoz Canada, Inc.
Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes injections & ophthalmic pharmaceutical products | Health Technology |
Rhône-Poulenc, Inc. | Process Industries |
Hoechst Marion Roussel Canada, Inc. |
